Palantir stock price drops as UK defence deal and ICE scrutiny put government work back in focus
28 January 2026
1 min read

Palantir stock price drops as UK defence deal and ICE scrutiny put government work back in focus

New York, Jan 28, 2026, 11:03 EST — Regular session

  • Palantir shares dropped roughly 2% in late-morning trading, moving against the broader market rally driven by AI-related names.
  • Investors approaching earnings season are weighing a new UK defence contract alongside fresh scrutiny of Palantir’s U.S. immigration projects.
  • Palantir is set to release its quarterly results after the close on Feb. 2.

Palantir Technologies (PLTR.O) shares dropped roughly 2% on Wednesday, continuing a decline that’s put the data-analytics company behind an AI-driven rally in the broader market. The stock slipped $3.31 to $162.39 in late-morning trading, after dipping as low as $161.95.

The move comes as investors juggle Federal Reserve signals with earnings reports from top tech giants, fueling sharp daily shifts in AI-related stocks. “You could definitely have a continuation on the rally in equities if the earnings season shows that AI expenditure is bringing in revenues,” said Jeff Leschen, managing director at Bramshill Investments. 1

Palantir is back in the spotlight with government contracts. The UK Ministry of Defence has directly awarded Palantir’s British division a £240.6 million, three-year enterprise agreement — basically a licensing and support contract — set to begin April 1, according to The Register, which cited a contract notice. The deal was reportedly signed on Dec. 30. An MoD spokesperson told the publication, “We conduct comprehensive due diligence on any business appointments that may lead to concern.” 2

In the U.S., Palantir is facing renewed internal resistance over its relationship with U.S. Immigration and Customs Enforcement, according to Wired. Following the weekend shooting of a Minneapolis nurse by federal agents, employees voiced concerns on a company-wide Slack channel. Palantir’s internal wiki flagged potential “reputational risk” linked to immigration enforcement contracts. Executive Akash Jain acknowledged the issue, stating: “Yes, we do not take the position of policing the use of our platform for every workflow.” 3

Palantir’s pitch centers on software that extracts patterns from messy data for governments and businesses. It has pushed its AI angle aggressively as budgets tilt toward automation. That strategy can attract buyers, but it also makes the stock jittery when political tensions flare.

Palantir is gearing up to release its fourth-quarter and full-year 2025 results on Monday, Feb. 2, right after the U.S. markets shut down. The company will hold a webcast at 5 p.m. ET to discuss the numbers. 4

But there’s a catch investors can’t ignore: Palantir’s heavy public-sector ties, which drive its biggest contracts, also leave it vulnerable to issues beyond its control. Procurement reviews, immigration debates, and potential contract delays can sour sentiment fast, even if revenue remains unaffected for now.

Traders will focus on the Fed decision and megacap tech earnings for the remainder of Wednesday. Then all eyes turn to Feb. 2, when Palantir’s outlook is expected to shape the next move in PLTR.

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears
Previous Story

Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears

UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates
Next Story

UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

Go toTop